Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 12 studies | 27% ± 9% | |
astrocyte | 6 studies | 34% ± 13% | |
oligodendrocyte | 6 studies | 25% ± 8% | |
endothelial cell | 5 studies | 21% ± 4% | |
endothelial cell of lymphatic vessel | 5 studies | 23% ± 8% | |
GABAergic neuron | 5 studies | 29% ± 10% | |
oligodendrocyte precursor cell | 5 studies | 24% ± 7% | |
glutamatergic neuron | 4 studies | 44% ± 12% | |
interneuron | 4 studies | 34% ± 16% | |
epithelial cell | 3 studies | 24% ± 6% | |
adipocyte | 3 studies | 17% ± 0% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 36% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 709.78 | 1440 / 1445 | 99% | 6.20 | 181 / 183 |
thymus | 100% | 1255.71 | 653 / 653 | 98% | 7.54 | 595 / 605 |
breast | 100% | 877.45 | 459 / 459 | 97% | 7.57 | 1089 / 1118 |
brain | 100% | 550.28 | 2633 / 2642 | 98% | 6.18 | 689 / 705 |
uterus | 100% | 1207.91 | 170 / 170 | 97% | 7.32 | 444 / 459 |
pancreas | 99% | 445.56 | 325 / 328 | 97% | 5.06 | 172 / 178 |
lung | 99% | 749.57 | 573 / 578 | 96% | 5.32 | 1107 / 1155 |
bladder | 100% | 901.86 | 21 / 21 | 93% | 5.02 | 469 / 504 |
kidney | 100% | 818.02 | 89 / 89 | 91% | 6.33 | 818 / 901 |
prostate | 100% | 1055.44 | 245 / 245 | 91% | 4.33 | 455 / 502 |
stomach | 99% | 610.29 | 357 / 359 | 90% | 4.82 | 258 / 286 |
intestine | 100% | 890.14 | 966 / 966 | 86% | 4.36 | 455 / 527 |
adrenal gland | 99% | 637.46 | 256 / 258 | 86% | 4.51 | 197 / 230 |
ovary | 100% | 1089.95 | 180 / 180 | 83% | 3.80 | 357 / 430 |
skin | 100% | 641.83 | 1808 / 1809 | 81% | 4.98 | 382 / 472 |
liver | 94% | 290.00 | 212 / 226 | 51% | 2.02 | 208 / 406 |
spleen | 100% | 880.71 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.53 | 1 / 1 |
blood vessel | 100% | 854.64 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 846.28 | 1202 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 6.25 | 43 / 45 |
heart | 95% | 366.72 | 815 / 861 | 0% | 0 | 0 / 0 |
muscle | 90% | 266.68 | 719 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 79% | 4.18 | 23 / 29 |
peripheral blood | 71% | 351.11 | 655 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 44% | 1.92 | 35 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060271 | Biological process | cilium assembly |
GO_0005814 | Cellular component | centriole |
GO_0005879 | Cellular component | axonemal microtubule |
GO_0005813 | Cellular component | centrosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0034451 | Cellular component | centriolar satellite |
GO_0005819 | Cellular component | spindle |
GO_0005515 | Molecular function | protein binding |
Gene name | CEP162 |
Protein name | Centrosomal protein of 162 kDa Centrosomal protein of 162 kDa (Cep162) (Protein QN1 homolog) |
Synonyms | C6orf84 QN1 KIAA1009 |
Description | FUNCTION: Required to promote assembly of the transition zone in primary cilia. Acts by specifically recognizing and binding the axonemal microtubule. Localizes to the distal ends of centrioles before ciliogenesis and directly binds to axonemal microtubule, thereby promoting and restricting transition zone formation specifically at the cilia base. Required to mediate CEP290 association with microtubules. . |
Accessions | ENST00000403245.8 [Q5TB80-1] ENST00000257766.8 [Q5TB80-2] ENST00000617909.2 [Q5TB80-2] Q5TB80 F6V2J0 ENST00000435955.1 |